Skip to main content
. 2023 Nov 2;8(6):e00724-23. doi: 10.1128/msystems.00724-23

TABLE 1.

Characteristics of data setsa

Type of samples Age N
(individuals)
N
(samples)
Sequencing information Culture results Disease Origin Reference
NP 2 mo 223 223 2 × 150 bp paired-end sequencing; Illumina HiSeq; 11.4 Gb (mean) 119 of 221 (54%; SP),
69 of 222 (31%; HI),
75 of 222 (33%; MC)
92 of 222 (41; SA)
H BD (18)
NP 4 mo 199 199 2 × 150 bp paired-end sequencing; Illumina HiSeq; 11.4 Gb (mean) 129 of 198 (65%; SP), 93 of 198 (47%; HI),
75 of 198 (38%; MC)
30 of 198 (15%; SA)
H BD (18)
OP <4 yr 15 96 NovaSeq 6000 PE150; 10 G of raw data per sample 26 (27%; HI),
38 (40%; SA),
5 (5%; PA)
CF CH This study
OP 4–6 yr 15 87 NovaSeq 6000 PE150; 10 G of raw data per sample 31 (36%; HI),
36 (41%; SA),
5 (6 %; PA)
CF CH This study
OP 6–8 yr 14 60 NovaSeq 6000 PE150; 10 G of raw data per sample 19 (32%; HI),
34 (57%; SA),
1 (2%; PA)
CF CH This study
OP >8 yr 8 16 NovaSeq 6000 PE150; 10 G of raw data per sample 8 (50%; HI),
15 (94%; SA)
CF CH This study
a

The total number of samples with available cultures from the NP samples are: M. catarrhalis (MC) (N = 378), H. influenzae (HI) (N = 380), S. pneumoniae (SP) (N = 377), and S. aureus (SA) (N = 375). Pseudomonas aeruginosa (PA) was only cultured for OP samples. For 1 OP sample, age was not available. Healthy individuals (H) and individuals with cystic fibrosis (CF) were included from Bangladesh (BD) and Switzerland (CH), respectively. Individuals were aged from 2 mo up to 10 yr.